BioCardia (BCDA) EBITDA Margin Growth (3y) (2016 - 2024)
Powered by 
Analysis
BioCardia (BCDA) EBITDA Margin Growth (3y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1,354.00 |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -4.99 Mn |
| Mar 31, 2024 | 232,451.00 |
| Dec 31, 2023 | -842,642.00 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 520,913.00 |
| Mar 31, 2023 | 664,457.00 |
| Dec 31, 2022 | -120,298.00 |
| Sep 30, 2022 | 22,001.00 |
| Jun 30, 2022 | 411,816.00 |
| Mar 31, 2022 | -383,806.00 |
| Dec 31, 2021 | -82,761.00 |
| Sep 30, 2021 | 392,016.00 |
| Jun 30, 2021 | -369,585.00 |
| Mar 31, 2021 | -464,177.00 |
| Dec 31, 2020 | -408,135.00 |
| Sep 30, 2020 | -897,995.00 |
| Jun 30, 2020 | -1.06 Mn |
| Mar 31, 2020 | -1.00 Mn |
| Dec 31, 2019 | 89,012.00 |
| Sep 30, 2019 | -22,580.00 |